Rossi Noreen F, Zhang Fong, Chen Haiping
Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Neurol Res. 2011 Mar;33(2):169-75. doi: 10.1179/016164111X12881719352336.
These studies were designed to test whether chronic central administration of endothelin-1 induces changes in systemic hemodynamics and plasma vasopressin similar to those observed with acute microinjections of endothelin-1.
Sprague Dawley rats underwent sham denervation or sinoaortic denervation. Three days later, baseline mean arterial blood pressure, heart rate, and vasopressin were assessed in conscious rats. Then, a cannula was stereotaxically inserted into the lateral ventricle and attached to an osmotic minipump that delivered one of the following: (i) artificial cerebrospinal fluid; (ii) endothelin-1, 10 pmol/hour; (iii) BQ-123, 400 pmol/hour; or (iv) endothelin-1+BQ-123. Mean arterial blood pressure and heart rate were monitored daily and blood was obtained for plasma vasopressin on days 3 and 9. On day 10, the rats were euthanized, the hypothalami were removed, and vasopressin messenger ribonucleic acid content was assessed.
The pressor effect of intracerebroventricular endothelin-1 was similar in intact and sinoaortic denervation rats and was prevented by endothelin receptor A antagonism with BQ-123. Administration of BQ-123 alone resulted in a depressor and bradycardia in sinoaortically denervated rats. Chronic endothelin-1 administration did not change plasma vasopressin but resulted in a significant decrease in hypothalamic vasopressin messenger ribonucleic acid levels, which was reversed by endothelin receptor A inhibition.
Although the pressor effect of chronic central endothelin-1 is similar to that reported with acute endothelin-1, plasma vasopressin levels do not increase, at least in part, due to downregulation of hypothalamic vasopressin gene expression. Sinoaortic denervation increases endogenous central endothelin receptor A tone. Furthermore, these observations confirm that the pressor effect of central endothelin-1 is not mediated by plasma vasopressin.
这些研究旨在测试长期经中枢给予内皮素 -1 是否会引起全身血流动力学和血浆血管加压素的变化,这些变化类似于急性微量注射内皮素 -1 时所观察到的变化。
将斯普拉格 - 道利大鼠进行假去神经支配或窦主动脉去神经支配。三天后,在清醒大鼠中评估基线平均动脉血压、心率和血管加压素。然后,通过立体定位将套管插入侧脑室,并连接到一个渗透微型泵,该泵输送以下物质之一:(i)人工脑脊液;(ii)内皮素 -1,10 pmol/小时;(iii)BQ -123,400 pmol/小时;或(iv)内皮素 -1 + BQ -123。每天监测平均动脉血压和心率,并在第3天和第9天采集血液以测定血浆血管加压素。在第10天,对大鼠实施安乐死,取出下丘脑,并评估血管加压素信使核糖核酸含量。
完整大鼠和窦主动脉去神经支配大鼠中,脑室内注射内皮素 -1 的升压作用相似,并且用 BQ -123 拮抗内皮素 A 受体可阻止这种作用。单独给予 BQ -123 会导致窦主动脉去神经支配大鼠出现降压和心动过缓。长期给予内皮素 -1 不会改变血浆血管加压素,但会导致下丘脑血管加压素信使核糖核酸水平显著降低,而内皮素 A 受体抑制可使其逆转。
尽管长期中枢给予内皮素 -1 的升压作用与急性给予内皮素 -1 时报道的相似,但血浆血管加压素水平并未升高,至少部分原因是下丘脑血管加压素基因表达下调。窦主动脉去神经支配会增加内源性中枢内皮素 A 受体张力。此外,这些观察结果证实中枢内皮素 -1 的升压作用不是由血浆血管加压素介导的。